United Kingdom
PhoreMost Ltd, founded in 2014, is a biopharmaceutical and biotechnology innovator located in Cambridge, UK. With the ambitious slogan, "Drugging the Undruggable®", the company leverages its proprietary technology, SITESEEKER®, along with PROTEINi® libraries to identify and target novel drug possibilities. This approach aims to address challenging disease areas, such as cancer, by expanding the 'druggable' landscape, potentially increasing therapeutic diversity and affordability.
The company focuses on creating a pipeline of breakthrough drug discovery programs, collaborating with academic and industrial partners worldwide to enhance drug discovery's speed and effectiveness. PhoreMost has established PhoreAll and PhorEST initiatives to promote inclusivity and sustainability.
In a significant growth phase, PhoreMost secured a $12.00M Series B investment on 12 September 2024. Notable investors include Parkwalk Advisors, Amadeus Capital Partners, Astellas Venture Management, Jonathan Milner, and Business Growth Fund.
